Edge
StocktwitsEarnings

Official STOCKTWITS Representative
$ADPT Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.25 down -47.06% YoY
• Reported revenue of $71.55M up 21.53% YoY
• Adaptive Biotechnologies expects full year MRD revenue between $268 million and $278 million, while total company operating expenses, including cost of revenue, are forecast between $350 million and $355 million.